Page last updated: 2024-10-31

metoprolol and Depressive Disorder, Major

metoprolol has been researched along with Depressive Disorder, Major in 2 studies

Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.

Depressive Disorder, Major: Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5)

Research Excerpts

ExcerptRelevanceReference

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bickel, A1
Kornhuber, J1
Maihöfner, C1
Ropohl, A1
Räsänen, P1
Hakko, H1
Tiihonen, J1

Other Studies

2 other studies available for metoprolol and Depressive Disorder, Major

ArticleYear
Exacerbation of migraine attacks during treatment with the selective serotonin reuptake inhibitor sertraline. A case report.
    Pharmacopsychiatry, 2005, Volume: 38, Issue:6

    Topics: Adrenergic beta-Antagonists; Antimanic Agents; Depressive Disorder, Major; Female; Humans; Lithium;

2005
Mitchell B. Balter Award--1998. Pindolol and major affective disorders: a three-year follow-up study of 30,485 patients.
    Journal of clinical psychopharmacology, 1999, Volume: 19, Issue:4

    Topics: Adrenergic beta-Antagonists; Atenolol; Depressive Disorder, Major; Disability Evaluation; Drug Thera

1999